EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineered Pseudomonas aeruginosa phages with quorum-quenching enzyme or depolymerase for inhibition of biofilm formation

Xi Luo, Siyun Wang, Yongqing Yang, Ruyue Gao, Shengjian Yuan, Jialin Yu, Dong Liu, Xin Tan

Frontiers in Microbiology · 13.01.2026 · 16

DOI: 10.3389/fmicb.2025.1752980 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 13.01.2026. Verfasst von Xi Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Affiliated Hospital of Zunyi Medical University (Guizhou Children's Hospital), Zunyi, Guizhou, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pseudomonas aeruginosa is a major cause of healthcare-associated infections and a significant threat to global health, primarily due to its ability to form biofilms that protect it from host immune responses and block antibiotic efficacy. While bacteriophages (phages) are emerging as potential antimicrobial agents, their effectiveness is often limited by these bacterial biofilms. This study aimed to enhance the biofilm-disrupting capabilities of phages through genetic engineering. First, we validated the in vitro biofilm-inhibitory effects of two enzymes: the quorum-quenching lactonase ( Aiia ) and a phage-derived depolymerase ( DP ). To demonstrate their potential, we then used CRISPR-Cas9 to engineer the P. aeruginosa phage PaGZ-1 to express these biofilm-disrupting genes. The resulting engineered phages demonstrated superior inhibition of biofilm formation compared to the wild-type phage. Notably, the PaGZ-1-Aiia variant showed significant promise in both inhibiting biofilm formation and disrupting established biofilms. Our findings provide a straightforward method for introducing exogenous genes into non-model P. aeruginosa phage genomes, offering a novel and potentially effective strategy for combating drug-resistant, biofilm-forming infections.

Schlagwörter

Stichwörter der Autor:innen

CRISPR-Cas9Pseudomonas aeruginosabiofilmdepolymerasephage engineeringquorum-quenching lactonase

Autor:innen und Institutionen

  • Department of Pediatrics, Affiliated Hospital of Zunyi Medical University (Guizhou Children's Hospital), Zunyi, Guizhou, China.
  • State Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
  • Department of Neonatology, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Pediatrics, Chongqing, China.
  • Department of Neonatology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.

Zitieren

APA

Luo, X., Wang, S., Yang, Y., Gao, R., Yuan, S., Yu, J., Liu, D., & Tan, X. (2026). Engineered Pseudomonas aeruginosa phages with quorum-quenching enzyme or depolymerase for inhibition of biofilm formation. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1752980

Vancouver

Luo X, Wang S, Yang Y, Gao R, Yuan S, Yu J, et al. Engineered Pseudomonas aeruginosa phages with quorum-quenching enzyme or depolymerase for inhibition of biofilm formation. Frontiers in Microbiology. 2026;16. doi:10.3389/fmicb.2025.1752980

BibTeX
@article{Luo2026,
  author = {Luo, Xi and Wang, Siyun and Yang, Yongqing and Gao, Ruyue and Yuan, Shengjian and Yu, Jialin and Liu, Dong and Tan, Xin},
  title = {Engineered Pseudomonas aeruginosa phages with quorum-quenching enzyme or depolymerase for inhibition of biofilm formation},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fmicb.2025.1752980}
}
Kostenlos starten →